In addition, the tau tracer [18F]PM-PBB3 has been shown to facilitate the detection of distinct patterns in patients with PSP and CBD compared to AD, indicating its capability for differential diagnosis [9]. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.